Afya Management and Innovation
helping build wealthier and healthier society
BioMab x Afya
BioMab is;
a precision medicine company based in Taiwan, specializing in immunology-driven therapeutic and diagnostic innovations.
Founded as a spin-out from Taiwan’s prestigious national research institute, Academia Sinica, BioMab is a pioneering academic-industry venture committed to advancing collaborative innovation in healthcare.
Guided by the vision, “Improving Human Health through Innovations,” BioMab aspires to become a global leader in immune-based precision medicine, dedicating to supporting healthcare professionals and researchers, while striving to provide every patient with more personalized care and a better quality of life.
At Afya Management and Innovation,
we are driven by our mission: help people worldwide, lead healthier, wealtheir, and more fulfilling lives, transcending geographical boundaries. With a deep commitment to BioMab’s vision and values, we are honored to serve as the official distribution partner of BioMab products in Japan.Our role is to ensure that the innovative research outcomes born in Taiwan can be fully utilized to advance the work of researchers and clinicians across Japan.
BioMab is more than just a product provider—it is a company that listens closely to the needs of researchers, incorporating their feedback into ongoing product development and refinement.
Together, we aim to serve as a bridge between Taiwanese research innovation and the Japanese medical and scientific community, contributing to the advancement of high-quality healthcare for all.
Human Platelet Lysate (hPL)
This human platelet lysate is formulated using FDA-approved blood components sourced in the United States, ensuring quality.
Designed as a cell culture supplement, it offers great lot-to-lot consistency and supports enhanced cell proliferation1).
By accelerating culture timelines, it helps minimize risks associated with cellular senescence and loss of differentiation potential, while also reducing prolonged use of incubator space—ultimately contributing to greater research efficiency.
This product is pre-supplemented with heparin.
1) Recommended for an use with mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, and umbilical cord blood.
1
For Product Tester
free trial sample 10mL
(Researc Use Only)
0 JPY
We invite you to try a complimentary 10 mL research-grade sample of BioMab human platelet lysate (hPL).
Participants who provide feedback after use (estimated time: approx. 10 minutes) will receive a 10% discount on their next order.*